Sponsor study identifier
interventional
75
1 country
1
Study Start
May 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2008
Actual (reported)Study Completion
December 2008
Actual (reported)It is the aim of this multicentric clinical study to assess the efficacy and tolerability of zoledronic acid in combination with radiotherapy in patients with advanced osteolytic bone lesions in terms of the reduction of pain and analgesic consumption.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2008
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 2002
Date type not reportedThis date has not been verified as actual or estimated.
September 13, 2005
Actual (reported)September 15, 2005
Actual (reported)December 2008
Actual (reported)December 2008
Actual (reported)Pain reduction
weekly assessments during 48 weeks
Time to pain reduction
weeks 0, 12, 24, 36, 48 and 60
Duration of pain reduction
weeks 0, 12, 24, 36, 48 and 60
Quality of life
weeks 0, 12, 24, 36, 48 and 60
zoledronic acid every 4 weeks in combination with radiotherapy
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Treatment programme
Zoledronic acid in combination with therapy
The registry describes a treatment programme. Individual components, doses and actual administration are not established by this entry.
View registry recordNovartis Investigative Site
Herne, Germany
Novartis Pharmaceuticals
Novartis Pharmaceuticals
75 participants (actual enrollment reported by the registry).
First Submitted
September 13, 2005
First Posted
September 15, 2005
Study Start
May 2002
Date type not reportedThis date has not been verified as actual or estimated.
Changes in parameters of bone turnover
weeks 0, 12, 24, 36, 48 and 60
Contact the study team to confirm eligibility.
Primary Completion
December 2008
Actual (reported)Study Completion
December 2008
Actual (reported)Last Updated
June 1, 2017
Record last verified: 2012-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: